Sign in
4

Changes in Ownership

Bausch Health Companies Inc. Filed Acc 0000899243-22-008822

U.S. President-Pharma Business gave up 8,925 shares (to pay taxes)

  • U.S. President-Pharma Business acquired 15,615 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spurr Robert U.S. President-Pharma Business 2022-02-27 Option exercise +15,615 75,914 D: show line 1 in the form
Spurr Robert U.S. President-Pharma Business 2022-02-27 Shares withheld for taxes −5,646 $24.35 $137,480 70,268 D: show line 2 in the form
Spurr Robert U.S. President-Pharma Business 2022-02-26 Shares withheld for taxes −1,628 $24.35 $39,642 68,640 D: show line 3 in the form
Spurr Robert U.S. President-Pharma Business 2022-02-27 Shares withheld for taxes −1,651 $24.35 $40,202 66,989 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Spurr Robert U.S. President-Pharma Business 2022-02-27 Grant or award · Restricted Share Units +15,615 0 D: show line 5 in the form
Spurr Robert U.S. President-Pharma Business 2022-02-27 Option exercise · Restricted Share Units −15,615 $24.35 $380,225 0 D: show line 6 in the form
Loading xslF345X03/doc4.xml…